Gerald Hogue
Vorstandsvorsitzender bei Viviphi Ltd.
Aktive Positionen von Gerald Hogue
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Vorstandsvorsitzender | 01.11.2015 | - |
Vorsitzender | 01.11.2015 | - | |
Gründer | 01.11.2015 | - | |
Präsident | 01.11.2015 | - | |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Direktor/Vorstandsmitglied | 01.12.2020 | - |
Karriereverlauf von Gerald Hogue
Ehemalige bekannte Positionen von Gerald Hogue
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POIT BIOP | Direktor/Vorstandsmitglied | 30.06.2021 | 27.12.2023 |
Independent Dir/Board Member | 30.06.2021 | 27.12.2023 | |
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Gründer | 01.01.1993 | - |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Founder | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sektoral
Technology Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POIT BIOP | Health Technology |
Private Unternehmen | 3 |
---|---|
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Technology Services |
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Technology Services |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Börse
- Insiders
- Gerald Hogue
- Erfahrung